To avoid the potential off-target effects of CXCR2 inhibitor SB225002, further, we used anti-Ly6g blocking antibody (α-Ly6g) to deplete neutrophils in DEN/CCl4-induced HCC mice (Figure 2G-H). Here, CXCR2 is linked to hepatocellular carcinoma.